PetCaseFinder

Peer-reviewed veterinary case report

Cat symptoms and outcomes after Vipera palaestinae snake bites

By Lenchner, Itzik et al.·Published in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)·2014·Koret School of Veterinary Medicine·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: A retrospective evaluation of Vipera palaestinae envenomation in 18 cats: (2006-2011).

Species:
cat
Movement & jointsCats

Plain-English summary

Eighteen cats were treated for snake bites from the Palestine viper, showing symptoms like rapid breathing, lameness, and depression. Most of these incidents happened during the hot months and affected mainly young domestic shorthair cats that spent time outdoors. Blood tests revealed serious issues, including low platelet counts and prolonged clotting times. Unfortunately, four of the cats did not survive despite receiving treatments like antivenom and plasma. The study found that cats with lower body weight and temperature at the time of treatment were more likely to have a poor outcome.

People also search for: cat snake bite treatment · symptoms of snake envenomation in cats · Palestine viper cat bites · cat rapid breathing after snake bite

Abstract

OBJECTIVE: To describe the clinical signs, clinicopathologic abnormalities, treatment, complications and outcome, and to identify risk factors for death in cats envenomed by Vipera palaestinae (Vp). DESIGN: Retrospective study. SETTING: Veterinary teaching hospital. ANIMALS: Eighteen client-owned cats envenomed by Vp. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: All envenomations occurred during the hot season (May to October), mostly in young (<4 years, 66%) domestic shorthair, outdoor or indoor-outdoor cats. Clinical signs included tachypnea (>40/min, 100%), lameness (78%), depression (71%), fang penetration marks (55%), hypothermia (<37.5&#xb0;C, 43%), hematoma at the envenomation site (27%), tachycardia (>220/min, 20%), and bradycardia (<140/min, 20%). Hematologic abnormalities included thrombocytopenia (89%), hemoconcentration (33%), and leukocytosis (33%). The activated partial thromboplastin and prothrombin times were prolonged in 100% and in 93% of the cats at presentation to a veterinarian, and remained prolonged 12-24 hours later in 92% and in 77% of the cats, respectively. Cats displayed increased serum creatine kinase activity (100%) and hyperglycemia (89%). Four cats (22%) did not survive. Median hospitalization time was 2 days. Variables associated with death included lower body weight (P = 0.01), lower initial rectal temperature (P = 0.02), lower initial hematocrit (P < 0.001) and 12-24 hours later (P = 0.001), and lower total plasma protein at 12-24 hours following presentation (P = 0.001). There was no association between death and administration of antivenom (10 mL/cat), fresh frozen plasma, or corticosteroids. CONCLUSIONS: Cats are at least as susceptible as dogs to Vp envenomation. Lower body weight, rectal temperature, and hematocrit at presentation were associated with nonsurvival.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/25154358/